BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24882708)

  • 1. Making drug policy together: reflections on evidence, engagement and participation.
    Roberts M
    Int J Drug Policy; 2014 Sep; 25(5):952-6. PubMed ID: 24882708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Policy Governance in the UK: lessons from changes to and debates concerning the classification of cannabis under the 1971 Misuse of Drugs Act.
    Monaghan M
    Int J Drug Policy; 2014 Sep; 25(5):1025-30. PubMed ID: 24635973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards good governance in drug policy: evidence, stakeholders and politics.
    MacGregor S; Singleton N; Trautmann F
    Int J Drug Policy; 2014 Sep; 25(5):931-4. PubMed ID: 25086908
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence-based policy or policy-based evidence? The role of evidence in the development and implementation of the Illicit Drug Diversion Initiative.
    Hughes CE
    Drug Alcohol Rev; 2007 Jul; 26(4):363-8. PubMed ID: 17564871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Political and legal institutions and their influence on drug policy: an Australian perspective.
    Ryder D
    Drug Alcohol Rev; 2008 Jul; 27(4):374-9. PubMed ID: 18584386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do drug policy makers access research evidence?
    Ritter A
    Int J Drug Policy; 2009 Jan; 20(1):70-5. PubMed ID: 18226519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What would an evidence based drug policy be like?
    Singleton N; Strang J
    BMJ; 2014 Dec; 349():g7493. PubMed ID: 25492041
    [No Abstract]   [Full Text] [Related]  

  • 8. What is good governance in the context of drug policy?
    Singleton N; Rubin J
    Int J Drug Policy; 2014 Sep; 25(5):935-41. PubMed ID: 24768218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peer, professional, and public: an analysis of the drugs policy advocacy community in Europe.
    O'Gorman A; Quigley E; Zobel F; Moore K
    Int J Drug Policy; 2014 Sep; 25(5):1001-8. PubMed ID: 24974366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflections of a forensic psychiatrist in Washington: politics and policy.
    Binder RL
    J Am Acad Psychiatry Law; 2004; 32(3):324-8. PubMed ID: 15515924
    [No Abstract]   [Full Text] [Related]  

  • 11. Governing through problems: the formulation of policy on amphetamine-type stimulants (ATS) in Australia.
    Fraser S; Moore D
    Int J Drug Policy; 2011 Nov; 22(6):498-506. PubMed ID: 22054738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legitimacy and modernity via policy transfer: the utility of the 2003 Afghan National Drug Control Strategy.
    Bewley-Taylor DR
    Int J Drug Policy; 2014 Sep; 25(5):1009-18. PubMed ID: 24835270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective drug policy: a new approach demonstrated in the Drug Policy Modelling Program.
    Ritter A; Bammer G; Hamilton M; Mazerolle L;
    Drug Alcohol Rev; 2007 May; 26(3):265-71. PubMed ID: 17454015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of evidence and the expert in contemporary processes of governance: the case of opioid substitution treatment policy in England.
    Duke K; Thom B
    Int J Drug Policy; 2014 Sep; 25(5):964-71. PubMed ID: 24582381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone, a contested substance: Danish methadone policy in the 1970s.
    Houborg E
    Int J Drug Policy; 2013 Nov; 24(6):e73-80. PubMed ID: 24120441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partnerships and communities in English drug policy: the challenge of deprivation.
    Macgregor S; Thickett A
    Int J Drug Policy; 2011 Nov; 22(6):478-90. PubMed ID: 21890338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug consumption rooms and the role of politics and governance in policy processes.
    Houborg E; Frank VA
    Int J Drug Policy; 2014 Sep; 25(5):972-7. PubMed ID: 24572642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Governance in EU illicit drugs policy.
    Edwards C; Galla M
    Int J Drug Policy; 2014 Sep; 25(5):942-7. PubMed ID: 25060612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why a governance perspective could contribute to improving drug policy and engaging the international development community: lessons from Colombia.
    Schultze-Kraft M
    Int J Drug Policy; 2014 Sep; 25(5):1038-9. PubMed ID: 24433814
    [No Abstract]   [Full Text] [Related]  

  • 20. Engagement of Sectors Other than Health in Integrated Health Governance, Policy, and Action.
    de Leeuw E
    Annu Rev Public Health; 2017 Mar; 38():329-349. PubMed ID: 28125390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.